Related Experiment Video
Updated: Nov 29, 2025
05:25
Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
Published on: December 29, 2021
2.8K
Cannabidiol in epilepsy: The indications and beyond
The Mental Health Clinician
|November 23, 2020
Summary
Cannabidiol shows promise for treating difficult epilepsy cases, including Lennox-Gastaut and Dravet syndromes. This study explores its use in specific patient cases, including off-label and nonprescription applications for epilepsy management.
Area of Science:
- Neurology
- Pharmacology
Background:
- Epilepsy affects many, with a significant portion experiencing treatment resistance.
- Lennox-Gastaut syndrome and Dravet syndrome are severe childhood-onset epilepsies with limited treatment options.
Purpose of the Study:
- To examine three distinct cases involving cannabidiol for epilepsy treatment.
- To explore the efficacy and application of cannabidiol in Lennox-Gastaut syndrome.
- To investigate off-label and nonprescription uses of cannabidiol in managing epilepsy.
Main Methods:
- Case study analysis of three patients with epilepsy.
- Review of cannabidiol's therapeutic potential in specific epilepsy syndromes.
- Evaluation of both FDA-approved and nonprescription cannabidiol formulations.
Main Results:
- Detailed presentation of a Lennox-Gastaut syndrome case treated with cannabidiol.
- Analysis of an off-label cannabidiol application for epilepsy management.
- Assessment of outcomes using nonprescription cannabidiol for epilepsy.
Conclusions:
- Cannabidiol presents a potential therapeutic avenue for refractory epilepsy, including specific childhood syndromes.
- Further investigation into off-label and nonprescription cannabidiol use is warranted.
- Case studies highlight the evolving role of cannabidiol in comprehensive epilepsy care.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
923
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
923
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
996
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
996
01:20Antiepileptic Drugs: Potassium Channel Activators
459
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
459
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
643
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
643
01:17Antiepileptic Drugs: Calcium Channel Blockers
920
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
920
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.3K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.3K